Pharma Mar (XMAD:PHM) Marketable Securities : €124.0 Mil (As of Mar. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Pharma Mar Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Pharma Mar's Marketable Securities for the quarter that ended in Mar. 2024 was €124.0 Mil.

Pharma Mar's annual Marketable Securities declined from Dec. 2021 (€88.5 Mil) to Dec. 2022 (€32.6 Mil) but then increased from Dec. 2022 (€32.6 Mil) to Dec. 2023 (€102.5 Mil).

Pharma Mar Marketable Securities Historical Data

The historical data trend for Pharma Mar's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharma Mar Marketable Securities Chart

Pharma Mar Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Marketable Securities

Get a 7-Day Free Trial

3.26

99.31

88.53

32.61

102.54

Pharma Mar Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Marketable Securities	Get a 7-Day Free Trial															63.42	108.83	104.38	102.54	124.01

Pharma Mar Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Pharma Mar (XMAD:PHM) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Pharma Mar Marketable Securities Related Terms

Thank you for viewing the detailed overview of Pharma Mar's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharma Mar (XMAD:PHM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharma Mar SA (XMAD:PHM) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

PHMMF:USA PHMe:UK 0RC6:UK

Address

Avenida de los Reyes, 1, Poligono Industrial La Mina-norte, Colmenar Viejo, Madrid, ESP, 28770

Website

http://www.pharmamar.com

Pharma Mar SA is engaged in the research, development, production, and commercialization of bio-active principles of marine origin for application in oncology. It also produces and market insecticides and air fresheners for household use, household products, wood treatment and decoration products, paints, and similar products. Its operating business segments are Oncology, Diagnostics, Consumer chemicals, and RNAi. The company obtains its revenues from two main areas: biopharmaceuticals and consumer chemicals, but the biopharmaceuticals is the main line of business.